Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TRISHIA MARIE FROST

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1417979774
CMS profile
6424104
Location
LINCOLN, NE

General Payments · PY2021–2024

$2,321.49

  • Reported across 117 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$860.62

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $860.62 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $410.58 18
Astellas Pharma US Inc $282.63 9
Novo Nordisk AS $53.42 3
Exact Sciences Corporation $20.88 1
Seqirus USA Inc $19.70 1
Actelion Pharmaceuticals US, Inc. $17.70 1
PFIZER INC. $14.14 1
Ardelyx, Inc. $14.10 1
Lilly USA, LLC $13.95 1
Acerta Pharma LLC $13.52 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $516.79 34
PY2022 $469.31 24
PY2023 $474.77 22
PY2024 $860.62 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.72 01/26/2024 Food and Beverage Undisputed 01/23/2026 1103758041 CMS
ABBVIE INC. $15.63 02/05/2024 Food and Beverage Undisputed 01/23/2026 1103758043 CMS
ABBVIE INC. $27.06 02/17/2024 Food and Beverage Undisputed 01/23/2026 1103758045 CMS
ABBVIE INC. $17.48 03/05/2024 Food and Beverage Undisputed 01/23/2026 1103758047 CMS
ABBVIE INC. $34.26 03/08/2024 Food and Beverage Undisputed 01/23/2026 1103758049 CMS
ABBVIE INC. $18.09 03/18/2024 Food and Beverage Undisputed 01/23/2026 1103758051 CMS
ABBVIE INC. $11.44 04/01/2024 Food and Beverage Undisputed 01/23/2026 1103758053 CMS
ABBVIE INC. $14.32 04/05/2024 Food and Beverage Undisputed 01/23/2026 1103758055 CMS
ABBVIE INC. $27.87 04/09/2024 Food and Beverage Undisputed 01/23/2026 1103758057 CMS
ABBVIE INC. $13.73 04/29/2024 Food and Beverage Undisputed 01/23/2026 1103758059 CMS
ABBVIE INC. $33.07 05/15/2024 Food and Beverage Undisputed 01/23/2026 1103758061 CMS
ABBVIE INC. $34.75 05/31/2024 Food and Beverage Undisputed 01/23/2026 1103758063 CMS
ABBVIE INC. $20.38 06/28/2024 Food and Beverage Undisputed 01/23/2026 1103758065 CMS
ABBVIE INC. $22.98 07/02/2024 Food and Beverage Undisputed 01/23/2026 1103758067 CMS
ABBVIE INC. $21.51 07/15/2024 Food and Beverage Undisputed 01/23/2026 1103758069 CMS
ABBVIE INC. $31.99 07/24/2024 Food and Beverage Undisputed 01/23/2026 1103758071 CMS
ABBVIE INC. $33.32 08/02/2024 Food and Beverage Undisputed 01/23/2026 1103758073 CMS
ABBVIE INC. $15.98 10/18/2024 Food and Beverage Undisputed 01/23/2026 1103758075 CMS
Actelion Pharmaceuticals US, Inc. $17.70 08/23/2024 Food and Beverage Undisputed 01/23/2026 1078899185 CMS
Ardelyx, Inc. $14.10 06/04/2024 Food and Beverage Undisputed 01/23/2026 1146727172 CMS
Astellas Pharma US Inc $24.86 02/13/2024 Food and Beverage Undisputed 01/23/2026 1139477234 CMS
Astellas Pharma US Inc $34.67 04/03/2024 Food and Beverage Undisputed 01/23/2026 1139484470 CMS
Astellas Pharma US Inc $23.85 06/25/2024 Food and Beverage Undisputed 01/23/2026 1139516693 CMS
Astellas Pharma US Inc $32.13 07/19/2024 Food and Beverage Undisputed 01/23/2026 1139465860 CMS
Astellas Pharma US Inc $33.71 08/05/2024 Food and Beverage Undisputed 01/23/2026 1139511535 CMS
Astellas Pharma US Inc $31.44 09/23/2024 Food and Beverage Undisputed 01/23/2026 1139534240 CMS
Astellas Pharma US Inc $34.68 10/29/2024 Food and Beverage Undisputed 01/23/2026 1139548943 CMS
Astellas Pharma US Inc $33.62 11/18/2024 Food and Beverage Undisputed 01/23/2026 1139554647 CMS
Astellas Pharma US Inc $33.67 12/13/2024 Food and Beverage Undisputed 01/23/2026 1139557059 CMS
AstraZeneca Pharmaceuticals LP $13.52 11/08/2024 Food and Beverage Undisputed 01/23/2026 1110535924 CMS
Exact Sciences Corporation $20.88 01/24/2024 Food and Beverage Undisputed 01/23/2026 1114527893 CMS
Lilly USA, LLC $13.95 08/20/2024 Food and Beverage Undisputed 01/23/2026 1135982027 CMS
Novo Nordisk Inc $19.92 01/06/2024 Food and Beverage Undisputed 01/23/2026 1100269790 CMS
Novo Nordisk Inc $15.07 05/04/2024 Food and Beverage Undisputed 01/23/2026 1100229318 CMS
Novo Nordisk Inc $18.43 06/08/2024 Food and Beverage Undisputed 01/23/2026 1100614947 CMS
PFIZER INC. $14.14 09/17/2024 Food and Beverage Undisputed 01/23/2026 1131976853 CMS
Seqirus USA Inc $19.70 12/03/2024 Food and Beverage Undisputed 01/23/2026 1125632794 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.